Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

Presentation TCT 2024

Are Late Complications of TAVR Unavoidable? A Personal Perspective

Presenter: Eric Van Belle

October 29, 2024

News Daily News

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

Yael L. Maxwell

December 18, 2023

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

Presentation TCT 2023

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

Presenter: Eric Van Belle

October 26, 2023

Presentation TCT 2023

Case Study: How to Perform Microvascular and Vasomotor Testing

Presenter: Eric Van Belle

October 24, 2023

News Daily News

New Microbleeds Not Uncommon Post-TAVI

Caitlin E. Cox

August 10, 2022

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News Daily News

Diabetes Does Not Appear to Hinder FFR Insights for CAD

Caitlin E. Cox

January 09, 2020

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

Presentation TCT 2018

Multivessel Disease: Should Invasive Physiology Change My Strategy?

Presenter: Anibal A. Damonte, Jacques Monsegu, Eric Van Belle

September 24, 2018

Presentation TCT 2018

Physiology Case Vignette #4: FFR Assessment of an ACS Non-Culprit Lesion

Presenter: William F. Fearon, Nils Johnson, Jung-Min Ahn, Thomas Engstrøm, Ole Fröbert, Habib Samady, Eric Van Belle, Frederik M. Zimmermann

September 24, 2018

Presentation TCT 2018

Physiology Case Vignette #3: FFR Guidance in Multivessel Disease

Presenter: William F. Fearon, Nils Johnson, Jung-Min Ahn, Thomas Engstrøm, Ole Fröbert, Habib Samady, Eric Van Belle, Frederik M. Zimmermann

September 24, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Presenter: Eric Van Belle

September 22, 2018

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

Presentation TCT 2017

Two-Stent Techniques: Different Options for Different Scenarios?

Presenter: Alejandro Cherro, Eric Van Belle

November 01, 2017

Presentation TCT 2017

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Presenter: Bernard Prendergast, Brian K. Whisenant, Eric Van Belle

November 01, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Advertisement

ESC/EACTS Release New Valvular Heart Disease Guidelines

Are Late Complications of TAVR Unavoidable? A Personal Perspective

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

Case Study: How to Perform Microvascular and Vasomotor Testing

New Microbleeds Not Uncommon Post-TAVI

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Diabetes Does Not Appear to Hinder FFR Insights for CAD

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Multivessel Disease: Should Invasive Physiology Change My Strategy?

Physiology Case Vignette #4: FFR Assessment of an ACS Non-Culprit Lesion

Physiology Case Vignette #3: FFR Guidance in Multivessel Disease

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Two-Stent Techniques: Different Options for Different Scenarios?

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content